CancerVax Completes Planned Enrollment in Phase 3 Clinical Trial of Canvaxin for the Treatment of Stage III Melanoma
In: Business Wire, 2004-09-22
Zeitungsartikel
Zugriff:
CARLSBAD, Calif. -- Phase 3 Trial for Stage IV Melanoma Continues to Enroll Patients CancerVax Corporation (NASDAQ:CNVX) announced today that it has completed the planned enrollment of 1,118 patients into [...]
Titel: |
CancerVax Completes Planned Enrollment in Phase 3 Clinical Trial of Canvaxin for the Treatment of Stage III Melanoma
|
---|---|
Zeitschrift: | Business Wire, 2004-09-22 |
Veröffentlichung: | 2004 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|